Evan F Lind (Evan Lind)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Regulatory T Cells

Chronic Lymphocytic Leukemia

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Kyle A Romine, Kevin MacPherson, Hyun-Jun Cho, Yoko Kosaka, Patrick A Flynn, Kaelan H Byrd, Jesse L Coy, Matthew T Newman, Ravina Pandita, Christopher P Loo, Jaime Scott, Andrew C Adey, Evan F Lind
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8 + T cells. Leukemia (2023)
Olivia M Lucero, Ji-Ann Lee, Jenna Bowman, Kara Johnson, Gopal Sapparapu, John K Thomas, Guang Fan, Bill H Chang, Karina Thiel-Klare, Christopher A Eide, Craig Okada, Mike Palazzolo, Evan F Lind, Yoko Kosaka, Brian J Druker, Nicholas Lydon, Peter M Bowers
Patient Specific Targeting of the T-cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Kyle A Romine, Kevin MacPherson, Hyun-Jun Cho, Yoko Kosaka, Patrick A Flynn, Kaelan H Byrd, Jesse L Coy, Matthew T Newman, Ravina Pandita, Christopher P Loo, Jaime Scott, Andrew C Adey, Evan F Lind
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8 + T cells. Leukemia 37 (3) (2023)
Kyle A Romine, Kevin MacPherson, Hyun-Jun Cho, Yoko Kosaka, Patrick A Flynn, Kaelan H Byrd, Jesse L Coy, Matthew T Newman, Ravina Pandita, Christopher P Loo, Jaime Scott, Andrew C Adey, Evan F Lind
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8 + T cells. Leukemia 37 (3) (2023)
Kyle A Romine, Kevin MacPherson, Hyun-Jun Cho, Yoko Kosaka, Patrick A Flynn, Kaelan H Byrd, Jesse L Coy, Matthew T Newman, Ravina Pandita, Christopher P Loo, Jaime Scott, Andrew C Adey, Evan F Lind
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8 + T cells. Leukemia 37 (3) (2023)
Kyle A Romine, Kevin MacPherson, Hyun-Jun Cho, Yoko Kosaka, Patrick A Flynn, Kaelan H Byrd, Jesse L Coy, Matthew T Newman, Ravina Pandita, Christopher P Loo, Jaime Scott, Andrew C Adey, Evan F Lind
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8 + T cells. Leukemia 37 (3) (2023)
Kyle A Romine, Kevin MacPherson, Hyun-Jun Cho, Yoko Kosaka, Patrick A Flynn, Kaelan H Byrd, Jesse L Coy, Matthew T Newman, Ravina Pandita, Christopher P Loo, Jaime Scott, Andrew C Adey, Evan F Lind
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8 + T cells. Leukemia 37 (3) (2023)
Scott Best, Vi Lam, Tingting Liu, Nur Bruss, Adam Kittai, Olga V Danilova, Susan Murray, Allison Berger, Nathan D Pennock, Evan F Lind, Alexey V Danilov
Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells. Leukemia 35 (1) (2020)